✦ LIBER ✦

PCN76 Economic Evaluation of the Use of Erlotinib for Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutation in Mexican Public Health Institutions

✍ Scribed by Lechuga, D.; Alva, M.; Gay, J.G.; Sánchez-Kobashi, R.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN34 PHARMAECONOMIC EVALUATION OF THE U

✍ C Tenorio; J Vargas; MI Pacheco; L González-Michaca 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

PCN110 Economic Evaluation of Gefitinib

✍ Fragoulakis, V.; Pallis, A.; Kourlaba, G.; Georgoulias, V.; Maniadakis, N. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCN77 PHARMACOECONOMIC ANALYSIS OF ERLOT

✍ O Batigun; E Yildirim 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

9150 Phase I trial of vorinostat in comb

✍ Reguart, N.; Isla, D.; Cardona, A.F.; Palmero, R.; Cardenal, F.; Rolfo, C.; Mont 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

PCN11 PHARMACOECONOMIC ANALYSES OF ERLOT

✍ I Côté; NB Leighl; M Gyldmark; B Maturi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PCN37 A Pharmacoeconomic Analysis of the

✍ J. Culig; M. Leppée; N. Skaron-Jakobovic 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB